Key statistics
As of last trade, Medipharm Labs Corp (MLZ:MUN) traded at 0.0402, 20.36% above the 52 week low of 0.0334 set on Nov 28, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.0402 |
|---|---|
| High | 0.0402 |
| Low | 0.0402 |
| Bid | 0.0368 |
| Offer | 0.0438 |
| Previous close | 0.0422 |
| Average volume | 55.56k |
|---|---|
| Shares outstanding | 424.86m |
| Free float | 399.03m |
| P/E (TTM) | -- |
| Market cap | 27.36m CAD |
| EPS (TTM) | -0.0193 CAD |
Data delayed at least 15 minutes, as of Feb 10 2026 08:23 GMT.
More ▼
Announcements
- MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO
- MediPharm Labs to Enter New Market with Costa Rica Supply Agreement
- Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience
- MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns
- MediPharm Labs Completes First Shipment to France
- MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law
- MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains
- MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results
- MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
- MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results
More ▼
